Health
Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels – News-Medical.Net
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
Based on their findings, the researchers say doctors may need to rethink how they dose the drug for certain groups of patients.
The team of scientists, based at the University of Virginia School of Medicine, the University of…
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoNew FLC President has regional lens – Proctor